Page 424 - TBE_Book_V2_2019

Chapter 12b: TBE in Switzerland/Liechtenstein

Table 2: TBE reporting and vaccine prevention in Switzerland
Notifiable disease since 1988
Mandatory TBE Tick bites and Lyme borreliosis have been reported via a sentinel group
reporting 5,9
(general practitioners and pediatricians in the entire country) since 2008
Case Laboratory criteria Clinical criteria
classification
Not a case Positive IgM serology No ILI & no neurological symptoms
Positive IgM ILI or non-specific neurological signs &
Possible case a)
serology symptoms
Positive IgM +
b) positive IgG Any
serology*
5
Categorization Probable a) Positive IgM Meningitis, meningoencephalitis,
case serology encephalomyelitis or pareses
Positive IgM + ILI or non-specific neurological signs or
b) positive IgG symptoms
serology*
Positive IgM +
Confirmed Meningitis, meningoencephalitis,
a) positive IgG
case encephalomyelitis, or pareses
serology*
TBE-RNA detection Meningitis, meningoencephalitis,
b)
by PCR encephalomyelitis, or pareses
IgG, immunoglobulin; IgG, immunoglobulin; ILI, influenza-like illness; PCR, polymerase chain reaction
*Or anti-TBE IgG serum antibody seroconversion or ≥4-fold rise in anti-TBE IgG serum antibodies
Special clinical No Swiss data
features
% with sequelae: 25%; mortality: 1%
®
Encepur N (Novartis/GSK)
Available FSME-Immun (Baxter/Pfizer)
®
10
vaccines
Number of doses sold: not available
Vaccination
recommendations Recommendations and reimbursement for vaccination in 2006
and
10
reimbursement
Average national vaccination uptake (3 doses), 2014-16:
Vaccine uptake by 8 years old: 22-31%
age group/risk 16 years old: 33-45%
group/general High-risk area (canton of Thurgau):
11
population 8 years old: 40-53%
16 years old: 64-75%
National Reference Center for Tick-borne Diseases, SPIEZ LABORATORY is a division of
Name, address/ the Federal Office for Civil Protection
website of TBE LABOR SPIEZ
NRC Austrasse
3700 SPIEZ - Switzerland
https://www.labor-spiez.ch/de/die/bio/dediebionrz.htm
nrzk@babs.admin.ch

419